GGrantIndex
Sort

8,912 grants matching sars cov 2

Autophagy and its Regulation in Diabetic Embryopathy

$400,000
Peixin Yang · University Of Maryland Baltimore · R01 · FY2023 · HD

Diagnosing and predicting risk in children with SARS-CoV-2- related illness

$400,000
Jane C Burns · University Of California, San Diego · R61 · FY2022 · HD

Equipping a newly renovated ABSL-3 suite with a "smart" biocontainment caging system

$400,000
James D. Macy · Yale University · R24 · FY2022 · OD

CAREER: New Statistical Approaches for Studying Evolutionary Processes: Inference, Attribution and Computation

$400,000
Julia Palacios · Stanford University · · FY2022 · MPS

Sentinel: RNA phage Qbeta displayed SARS-CoV-2 epitopes fused with Nanotag as a biosensor toolkit

$400,000
Alain Bopda Waffo · Indiana University · · FY2022 · ENG

Targeting IDO in SARS-CoV2-induced Alzheimer's Disease progression

$400,000
Irma Cisneros · University Of Texas Med Br Galveston · R56 · FY2022 · AG

RFA-IP-22-001 - Burden and sequelae of influenza, SARS-CoV-2 and other respiratory viruses associated Severe Acute Respiratory Infections among Indian adult population aged 18-60yrs

$400,000
Anand Krishnan · All-India Institute Of Medical Sciences · U01 · FY2025 · IP

COVID 19 Supplement - NIH TCF TASK AREA B-1

$400,000
John Altman · Emory University · N01 · FY2020 · AI

Epidemic Surge Model Use to Improve Patient, Staff, and System Safety and Resiliency

$399,999
James C Benneyan · Northeastern University · R01 · FY2024 · HS

Epidemic Surge Model Use to Improve Patient, Staff, and System Safety and Resiliency

$399,999
James C Benneyan · Northeastern University · R01 · FY2025 · HS

TELE-TOC: Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients - Resubmission - 1

$399,999
Valerie G Press · University Of Chicago · R01 · FY2023 · HS

Mount Sinai Health System Kidney Precision Medicine Project

$399,999
Steven G Coca · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · DK

Epidemic Surge Model Use to Improve Patient, Staff, and System Safety and Resiliency

$399,999
James C Benneyan · Northeastern University · R01 · FY2023 · HS

US-Cuba Administrative Supplement to the Viral Immunity and Vaccination (VIVA) Human Immunology Project Consortium

$399,999
Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI

TELE-TOC: Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients - Resubmission - 1

$399,991
Valerie G Press · University Of Chicago · R01 · FY2024 · HS

TELE-TOC: Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients - Resubmission - 1

$399,991
Valerie G Press · University Of Chicago · R01 · FY2025 · HS

Predicting Diabetic Retinopathy from Risk Factor Data and Digital Retinal Images

$399,963
Omolola Ijeoma Ogunyemi · Charles R. Drew University Of Med & Sci · R01 · FY2021 · LM

HIV-1 Env gp160 maturation in the Golgi apparatus

$399,750
Yong-Hui Zheng · University Of Illinois At Chicago · U01 · FY2024 · AI

HIV-1 Env gp160 maturation in the Golgi apparatus

$399,750
Yong-Hui Zheng · University Of Illinois At Chicago · U01 · FY2023 · AI

HIV-1 Env gp160 maturation in the Golgi apparatus

$399,750
Yong-Hui Zheng · University Of Illinois At Chicago · U01 · FY2025 · AI

Kinetic and structural basis for SARS-CoV-2 RNA-dependent RNA polymerase specificity and inhibition

$399,682
Kenneth Allen Johnson · University Of Texas At Austin · R01 · FY2024 · AI

Finding Protein Sequence Motifs--methods And Applications

$399,581
Eugene V Koonin · National Library Of Medicine · ZIA · FY2021 · LM

EVOLVING VIRUS-SPECIFIC sACE2 MIMICS FOR COMPETITIVE INHIBITION OF SARS-CoV-2

$399,346
Kevin Esvelt · Massachusetts Institute Of Technology · R21 · FY2020 · AI

Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease

$399,310
Michael G Rosenfeld · University Of California, San Diego · R01 · FY2024 · AG

Ultra-precision diagnostics for ALK+ non-small cell lung cancer

$399,153
David Randall Armant · Alelopharma Inc. · R43 · FY2025 · CA